Cayetano Miralles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Cayetano Miralles has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alba Moratalla
Alicante Institute for Health and Biomedical Research (ISABIAL), Hospital General Universitario Dr. Balmis, Alicante, Spain
1 shared publication - Amalia Tzoumpa
Alicante Institute for Health and Biomedical Research (ISABIAL), Hospital General Universitario Dr. Balmis, Alicante, Spain
1 shared publication - Beatriz Lozano-Ruiz
Alicante Institute for Health and Biomedical Research (ISABIAL), Hospital General Universitario Dr. Balmis, Alicante, Spain
1 shared publication - Fabián Tarín
Alicante Institute for Health and Biomedical Research (ISABIAL), Hospital General Universitario Dr. Balmis, Alicante, Spain
1 shared publication - Iván Herrera
Alicante Institute for Health and Biomedical Research (ISABIAL), Hospital General Universitario Dr. Balmis, Alicante, Spain
1 shared publication - Joanna Picó
Alicante Institute for Health and Biomedical Research (ISABIAL), Hospital General Universitario Dr. Balmis, Alicante, Spain
1 shared publication
Latest Publications
- Open Access
- 24 July 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (17)
Dietary salt intake worsens the Th17-dependent inflammatory profile of patients with cirrhosis
Background & Aims Liver cirrhosis is characterized by chronic inflammation and fibrosis, with Th17 cells playing a crucial role in its progression. Recent evidence suggests that dietary salt influences immune diseases by modulating Th17 differentiation. This study assessed the impact of dietary salt on Th17-driven inflammation in patients with compensated cirrhosis and explored its effects on liver injury in mouse models. Methods A non-drug, open-label, non-randomized study involved 37 patients with compensated cirrhosis, who were given personalized guidelines to reduce salt intake over three months. Changes in Th17-driven inflammation and liver function markers were assessed at baseline and after salt restriction. In parallel, the impact of a high-salt diet on hepatic CD4+ T cells was analyzed in mouse models of acute liver injury and fibrosis. Results High salt intake was associated with Th17-mediated inflammation and correlated with markers of impaired liver function in these patients. Importantly, moderating salt intake through a personalized nutritional intervention was sufficient to reduce CD4+ T cell- mediated inflammation. Furthermore, analysis of RNA-seq data revealed enrichment of salt-induced Th17 gene signatures in both liver tissue and peripheral cells from patients with liver disease. Similarly, mice fed a high salt diet showed hepatic enrichment of Th17 cells and exacerbated liver fibrosis upon injury. Mechanistic studies revealed that high sodium conditions activated NF-κB and induced IL-6 production in hepatocytes, which may promote Th17 responses. Conclusion Dietary salt exacerbates Th17-driven inflammation and contributes to cirrhosis progression. Salt reduction may represent a viable therapeutic approach to manage inflammation in compensated cirrhosis.
- 24 July 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (17)
Open AccessDietary salt intake worsens the Th17-dependent inflammatory profile of patients with cirrhosis
Background & Aims Liver cirrhosis is characterized by chronic inflammation and fibrosis, with Th17 cells playing a crucial role in its progression. Recent evidence suggests that dietary salt influences immune diseases by modulating Th17 differentiation. This study assessed the impact of dietary salt on Th17-driven inflammation in patients with compensated cirrhosis and explored its effects on liver injury in mouse models. Methods A non-drug, open-label, non-randomized study involved 37 patients with compensated cirrhosis, who were given personalized guidelines to reduce salt intake over three months. Changes in Th17-driven inflammation and liver function markers were assessed at baseline and after salt restriction. In parallel, the impact of a high-salt diet on hepatic CD4+ T cells was analyzed in mouse models of acute liver injury and fibrosis. Results High salt intake was associated with Th17-mediated inflammation and correlated with markers of impaired liver function in these patients. Importantly, moderating salt intake through a personalized nutritional intervention was sufficient to reduce CD4+ T cell- mediated inflammation. Furthermore, analysis of RNA-seq data revealed enrichment of salt-induced Th17 gene signatures in both liver tissue and peripheral cells from patients with liver disease. Similarly, mice fed a high salt diet showed hepatic enrichment of Th17 cells and exacerbated liver fibrosis upon injury. Mechanistic studies revealed that high sodium conditions activated NF-κB and induced IL-6 production in hepatocytes, which may promote Th17 responses. Conclusion Dietary salt exacerbates Th17-driven inflammation and contributes to cirrhosis progression. Salt reduction may represent a viable therapeutic approach to manage inflammation in compensated cirrhosis.